Literature DB >> 15377813

Autosomal dominant polycystic kidney disease and pain - a review of the disease from aetiology, evaluation, past surgical treatment options to current practice.

K K Badani1, A K Hemal, M Menon.   

Abstract

Autosomal Dominant Polycystic Kidney Disease (ADPKD), often referred to as "adult" polycystic kidney disease, is one of the commonest hereditary disorders. It affects approximately 4 to 6 million individuals worldwide. The disease progresses to end-stage renal disease and it accounts for 10-15% of patients requiring dialysis in the United States. A comprehensive Medline search for aetiology, evaluation, screening, cellular biology, and treatment was utilized to locate, extract, and synthesize relevant data with respect to this topic. Special attention was focused on urologic literature and surgical textbooks regarding operative treatment of pain associated with ADPKD. Now, patients with ADPKD have more treatment options. More specifically, several therapeutic alternatives are now available for the management of pain in these patients. A recent review of literature supports the performance of open or laparoscopic cyst decortication procedures for control of pain and infection without the worry of causing further renal impairment in those with preserved renal function.

Entities:  

Mesh:

Year:  2004        PMID: 15377813

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  8 in total

Review 1.  Current management of autosomal dominant polycystic kidney disease.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2015-09-06

2.  Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Antonio Concistrè; Luigi Petramala; Gianmarco Scoccia; Susanna Sciomer; Valeria Bisogni; Vincenza Saracino; Gino Iannucci; Silvia Lai; Daniela Mastroluca; Gianluca Iacobellis; Claudio Letizia
Journal:  Cardiorenal Med       Date:  2018-05-03       Impact factor: 2.041

Review 3.  Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy.

Authors:  Chrysoula Argyrou; Demetrios Moris; Spyridon Vernadakis
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

Review 4.  Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Sharonne N Hayes; Esther S H Kim; Jacqueline Saw; David Adlam; Cynthia Arslanian-Engoren; Katherine E Economy; Santhi K Ganesh; Rajiv Gulati; Mark E Lindsay; Jennifer H Mieres; Sahar Naderi; Svati Shah; David E Thaler; Marysia S Tweet; Malissa J Wood
Journal:  Circulation       Date:  2018-02-22       Impact factor: 29.690

5.  Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.

Authors:  Christian R Halvorson; Matthew S Bremmer; Stephen C Jacobs
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-06-24

6.  Diagnostic and therapeutic challenges of an ambiguous cystic kidney disease in a resource limited setting: a case report.

Authors:  Christian Akem Dimala; Ndemazie Nkafu Bechem; Benjamin Momo Kadia; Vitalis Fambombi Feteh; Simeon Pierre Choukem
Journal:  BMC Res Notes       Date:  2017-03-01

7.  Simultaneous ipsilateral nephrectomy during kidney transplantation in autosomal dominant polycystic kidney disease: a matched pair analysis of 193 consecutive cases.

Authors:  Bernd Martin Jänigen; Johann Hempel; Philipp Holzner; Johanna Schneider; Stefan Fichtner-Feigl; Oliver Thomusch; Hannes Neeff; Przemyslaw Pisarski; Torben Glatz
Journal:  Langenbecks Arch Surg       Date:  2020-07-23       Impact factor: 3.445

8.  Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians.

Authors:  Anna Baker; Dominic King; James Marsh; Andrew Makin; Alison Carr; Catherine Davis; Cara Kirby
Journal:  Clin Kidney J       Date:  2015-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.